What is he best known for?
The fields of study he is best known for:
- Acquired immunodeficiency syndrome
- Internal medicine
- Virus
Drug resistance, Virology, Acquired immunodeficiency syndrome, Reverse transcriptase and Immunology are his primary areas of study.
His Drug resistance study frequently draws connections between related disciplines such as Bioinformatics.
His Virology research is multidisciplinary, incorporating perspectives in Nevirapine, Raltegravir, CTL* and Major histocompatibility complex.
Jonathan M. Schapiro has included themes like Viral disease, Virus, Expanded access and Drug in his Acquired immunodeficiency syndrome study.
His Reverse transcriptase research focuses on subjects like Genotype, which are linked to Mutation, Protease, Pharmacotherapy, Global health and Proteases.
His Immunology research incorporates themes from Genotyping and Intensive care medicine.
His most cited work include:
- Update of the Drug Resistance Mutations in HIV-1. (1203 citations)
- Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update (707 citations)
- Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection: 2008 Recommendations of an International AIDS Society-USA Panel (469 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Virology, Drug resistance, Internal medicine, Immunology and Reverse transcriptase.
His studies deal with areas such as Protease inhibitor, Protease, Genotype and Saquinavir as well as Virology.
His Drug resistance research integrates issues from Bioinformatics, Acquired immunodeficiency syndrome, Viral load, HIV drug resistance and Drug.
Jonathan M. Schapiro interconnects Viral disease, Expanded access, Family medicine and Transmission in the investigation of issues within Acquired immunodeficiency syndrome.
The study incorporates disciplines such as Gastroenterology and Oncology in addition to Internal medicine.
His work in Immunology tackles topics such as Resistance mutation which are related to areas like Integrase.
He most often published in these fields:
- Virology (45.28%)
- Drug resistance (36.79%)
- Internal medicine (26.42%)
What were the highlights of his more recent work (between 2011-2021)?
- Virology (45.28%)
- Drug resistance (36.79%)
- Internal medicine (26.42%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Virology, Drug resistance, Internal medicine, Drug and Regimen.
Jonathan M. Schapiro is studying Stavudine, which is a component of Virology.
His study in Drug resistance is interdisciplinary in nature, drawing from both HIV drug resistance and Viral load.
His Internal medicine research includes themes of Gastroenterology and Rilpivirine.
His Drug research incorporates elements of Alternative medicine, Preclinical data and Intensive care medicine.
His work deals with themes such as Lamivudine, Efavirenz, Pharmacology and Zidovudine, which intersect with Regimen.
Between 2011 and 2021, his most popular works were:
- HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing (58 citations)
- Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine. (26 citations)
- Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen : An International Collaboration (23 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Acquired immunodeficiency syndrome
- Virus
Jonathan M. Schapiro mainly investigates Virology, Drug resistance, Regimen, Viral load and Stavudine.
His studies in Virology integrate themes in fields like Genotypic resistance, Antiretroviral therapy, Viral genetics and Artificial intelligence.
His Drug resistance study typically links adjacent topics like Cohort.
His Regimen research is multidisciplinary, relying on both Virological failure, Reverse transcriptase, Tenofovir and First line.
As a part of the same scientific study, he usually deals with the Viral load, concentrating on Integrase inhibitor and frequently concerns with Drug and Intensive care medicine.
His biological study spans a wide range of topics, including Nevirapine, Nucleoside Reverse Transcriptase Inhibitor and Efavirenz.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
